Amplimmune Immunology's Series A Round

Amplimmune Immunology raised a round of funding on April 17, 2007.

Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientifi…

Articles about Amplimmune Immunology's Series A Round: